ImmunoGen, Inc.
Anti-CD123 antibodies and conjugates and derivatives thereof
Last updated:
Abstract:
The present invention generally relates to antibodies, antigen-binding fragments thereof, polypeptides, and immunoconjugates that bind to CD123 antigen (the .alpha. chain of the interleukine 3 receptor, or IL-3R.alpha.). The present invention also relates to methods of using such CD123-binding molecules for diagnosing and treating diseases, such as B-cell malignancies.
Status:
Grant
Type:
Utility
Filling date:
22 Oct 2020
Issue date:
17 May 2022